Novo Nordisk Says CHMP Provides Positive Opinion For EU Label Update For Tresiba Based On Data From Switch Trials, Demonstrated Clinically Relevant Reductions In Hypoglycaemia Compared With Insulin Glargine U100
Paul Quintaro